Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

E2F as a target of hormone refractory prostate cancer

US Patent 9314497 · Granted Apr 19, 2016

Assignee

Inventors

View full patent text on Google Patents →